Premium
eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in C rohn's disease
Author(s) -
Pedersen N.,
Elkjaer M.,
Duricova D.,
Burisch J.,
Dobrzanski C.,
Andersen N. N.,
Jess T.,
Bendtsen F.,
Langholz E.,
Leotta S.,
Knudsen T.,
Thorsgaard N.,
Munkholm P.
Publication year - 2012
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12043
Subject(s) - infliximab , ehealth , medicine , disease , world wide web , health care , computer science , economics , economic growth
Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is administered every 8 weeks, but inter-patient variation in optimal treatment intervals may exist.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom